Matthew Scalo

Matthew Scalo

Contatto Relazioni con gli Investitori presso MYRIAD GENETICS, INC.
Finance
Health Technology
Consumer Services

Profilo

Matthew Scalo is Senior Vice President-Investor Relations at Myriad Genetics, Inc. since 2022.
Former roles include Senior Director-Investor Relations at Luminex Corp., Investor Relations Contact at NextGen Healthcare, Inc., Senior Research Analyst at Allspring Global Investments LLC, Research Analyst at Canaccord Adams, Inc. from 2004 to 2010, VP, Investor Relations & Corporate Development at Cutera, Inc., Associate at Broadpoint.
Gleacher Securities in 2003, and Research Analyst at Canaccord Genuity, Inc. in 2010.
Education includes an MBA from the University of Notre Dame and an undergraduate degree from the University of California, Davis.

Posizioni attive di Matthew Scalo

SocietàPosizioneInizio
MYRIAD GENETICS, INC. Contatto Relazioni con gli Investitori 01/08/2022

Precedenti posizioni note di Matthew Scalo

SocietàPosizioneFine
Analyst-Equity 31/12/2010
Analyst-Equity 22/04/2010
Analyst-Equity 31/12/2003
Analyst-Equity 31/12/2002
NEXTGEN HEALTHCARE, INC. Contatto Relazioni con gli Investitori -
Vedi nel dettaglio l'esperienza di Matthew Scalo

Formazione di Matthew Scalo

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

76

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Technology Services

Health Technology

Finance

Health Technology

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Finance

  1. Mercati
  2. Insiders
  3. Matthew Scalo